Latest News
Press background on Takeda Biopharmaceuticals India Private Limited
Company profile
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI), with expertise in immune and inflammatory diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions.
 Recent press releases
Takeda Emphasizes the Need for Cross-sectoral Alliances to Address the Burden of Vector-Borne Infectious Diseases

Takeda Biopharmaceuticals India Pvt. Ltd. (formerly Baxalta Bioscience India Private Limited) - a global values-based, R&D-driven biopharmaceutical leader – presented an industry perspective on the substantial need for vaccine equity and novel strategies for ... (more)
Share
Takeda Announces Partnership with BIRAC in India to Foster Healthcare Innovation

The local-to-global initiative will support healthcare innovation and technological advancement for comprehensive solutions catering to healthcare needs
Besides supporting healthcare startups, the partnership will also contribute to India’s aspiration of emerging as a US$300 billi... (more)
Share
Takeda Reiterates the Need of Equitable Access to Healthcare for Universal Impact

Takeda Biopharmaceuticals India Private Limited (formerly Baxalta Bioscience India Pvt Ltd) – a global values-based, R&D-driven biopharmaceutical leader in innovative healthcare solutions presented an industry perspective on equitable access to healthcare during the 5th edition of the Con... (more)
Share
Takeda Emphasizes Diversity, Equity, and Inclusion as Essential Elements of Work Culture to bring Equal Opportunities for all at the G20 Summit

Takeda Biopharmaceuticals India Pvt. Ltd. (formerly known as Baxalta Bioscience India Private Limited), a global values-based, R&D-driven biopharmaceutical leader, was invited to a dedicated session on diversity, equity, and inclusion (DE&I) conducted in collaboration with the Healthcare Bu... (more)
Share
Takeda India felicitated as one of The Economic Times Best Healthcare Brand 2023

Takeda Biopharmaceuticals India Pvt. Ltd. (formerly known as Baxalta Bioscience India Private Limited), a global values-based, R&D-driven biopharmaceutical leader has recently been recognized as one of The Economic Times Best Healthcare Brands 2023’. The recognition has been earned by the... (more)
Share
Public Health Initiatives by Takeda to Strengthen Health System for Rare Diseases in India

Takeda Biopharmaceuticals India Private Limited (formerly known as Baxalta Bioscience India Private Limited), a global values-based, R&D-driven biopharmaceutical leader conducted dissemination of its public health initiatives in strengthening the health system for rare diseases (RD) in India. T... (more)
Share
Takeda Showcases Digital Health Solutions at G20 Meeting in India

Takeda Biopharmaceuticals India Private Limited Showcased Digital Innovations - MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
The Three-Day Meeting was Held in Goa, India, from April 17th to April 19th, 2023, and Side Event was Focused on: ‘Citizen-Centric He... (more)
Share